Neuphoria Therapeutics (NEUP) CEO pay: $924,138 actually paid in FY2025
$NEUP · Neuphoria Therapeutics Inc.Data through FY2025 — latest proxy filed 2025-10-30, checked for new filings 2026-08-21. Every number links to its source.
0.2× the tracked-company median CEO pay ($3.9M).
Pay vs. Performance (Compensation Actually Paid)
What the CEO was actually paid, by fiscal year
What $100 invested was worth, company vs peer group
Pay-vs-Performance table
| FY | CEO pay on paper | CEO pay actually earned | Other top execs (avg) | Value of $100 invested since FY2023 | Same, peer group since FY2023 | Net income |
|---|---|---|---|---|---|---|
| 2025 | $951,343 | $924,138 | $254,362 | $101.57 | — | -$400,000 |
| 2024 | $751,875 | $750,550 | $294,788 | $10.97 | — | -$15.5M |
| 2023 | $2.1M | $1.2M | — | $31.47 | — | -$21.4M |
Frequently asked
How much did the NEUP CEO make in 2025?
$924,138 in Compensation Actually Paid (CAP) as Neuphoria Therapeutics Inc.'s CEO (the filing reports this year's PEO pay without tagging which named executive it belongs to), updated 2025-10-30.
What is pay vs. performance (PvP)?
An SEC disclosure (Item 402(v), required since FY2022) linking named-executive pay to company total shareholder return (TSR) over up to 5 years.
What is Compensation Actually Paid (CAP)?
CAP starts from the Summary Compensation Table total and adjusts equity awards to fair value as of each year-end/vesting date, rather than grant-date value — see the glossary entry for the full walk-through.
Also on NEUP: SEC & DOJ enforcement actions · CEO track-record ranking · Glossary